Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Sevelamer Carbonate Patent Expiration

Sevelamer Carbonate is Used for managing high levels of phosphate in the blood, often in patients with chronic kidney disease. It was first introduced by Sanofi Genzyme in its drug Renvela on Oct 19, 2007. 19 different companies have introduced drugs containing Sevelamer Carbonate.


Sevelamer Carbonate Patents

Given below is the list of patents protecting Sevelamer Carbonate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Renvela US9095509 Sachet formulation for amine polymers Dec 06, 2030 Genzyme
Renvela US7985418 Aliphatic amine polymer salts for tableting Oct 27, 2025 Sanofi
Renvela US5667775 Phosphate-binding polymers for oral administration Sep 16, 2014

(Expired)

 Genzyme
Renvela US5667775 Phosphate-binding polymers for oral administration Sep 16, 2014

(Expired)

 Sanofi
Renvela US5496545 Phosphate-binding polymers for oral administration Aug 11, 2013

(Expired)

 Genzyme
Renvela US5496545 Phosphate-binding polymers for oral administration Aug 11, 2013

(Expired)

 Sanofi
Renvela US6509013 Method of making phosphate-binding polymers for oral administration Aug 11, 2013

(Expired)

 Genzyme
Renvela US6509013 Method of making phosphate-binding polymers for oral administration Aug 11, 2013

(Expired)

 Sanofi
Renvela US6858203 Method of making phosphate-binding polymers for oral administration Aug 11, 2013

(Expired)

 Genzyme
Renvela US6858203 Method of making phosphate-binding polymers for oral administration Aug 11, 2013

(Expired)

 Sanofi
Renvela US7014846 Phosphate-binding polymers for oral administration Aug 11, 2013

(Expired)

 Genzyme
Renvela US7014846 Phosphate-binding polymers for oral administration Aug 11, 2013

(Expired)

 Sanofi
Renvela US7459151 Phosphate-binding polymers for oral administration Aug 11, 2013

(Expired)

 Genzyme
Renvela US7459151 Phosphate-binding polymers for oral administration Aug 11, 2013

(Expired)

 Sanofi



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Sevelamer Carbonate's patents.

Given below is the list recent legal activities going on the following patents of Sevelamer Carbonate.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 18 Jan, 2023 US9095509
Payment of Maintenance Fee, 12th Year, Large Entity 11 Jan, 2023 US7985418
Payment of Maintenance Fee, 12th Year, Large Entity 21 May, 2020 US7459151
Payment of Maintenance Fee, 4th Year, Large Entity 24 Jan, 2019 US9095509
Payment of Maintenance Fee, 8th Year, Large Entity 10 Jan, 2019 US7985418
Patent Issue Date Used in PTA Calculation
Critical
 04 Aug, 2015 US9095509
Recordation of Patent Grant Mailed
Critical
 04 Aug, 2015 US9095509
Issue Notification Mailed
Critical
 15 Jul, 2015 US9095509
Application Is Considered Ready for Issue
Critical
 07 Jul, 2015 US9095509
Dispatch to FDC 07 Jul, 2015 US9095509


Sevelamer Carbonate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sevelamer Carbonate Generic API Manufacturers

Several generic applications have been filed for Sevelamer Carbonate. The first generic version for Sevelamer Carbonate was by Aurobindo Pharma Ltd and was approved on Jun 13, 2017. And the latest generic version is by Shandong Xinhua Pharmaceutical Co Ltd and was approved on Oct 24, 2024.

Given below is the list of companies who have filed for Sevelamer Carbonate generic, along with the locations of their manufacturing plants worldwide.


1. AMNEAL PHARMS CO

Amneal Pharmaceuticals Co Gmbh has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.

Strength Dosage Form Availability Application Pathway TE code Launch Date
800MG

tablet Prescription ORAL AB Nov 28, 2017





2. ARTHUR GRP

Arthur Group Llc has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Arthur Grp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
800MG

tablet Prescription ORAL AB Mar 20, 2018





3. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.4GM/PACKET

for suspension Prescription ORAL AB Jun 13, 2017
800MG/PACKET

for suspension Prescription ORAL AB Jun 13, 2017
800MG

tablet Prescription ORAL AB Jul 17, 2017


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd
Sangareddy Aurobindo Pharma Limited
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Bachupally Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





4. BIONPHARMA

Bionpharma Inc has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Bionpharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
800MG/PACKET

for suspension Prescription ORAL AB May 17, 2021


Manufacturing Plant Locations
New

Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.

Country City Firm Name
United States
Princeton Bionpharma Inc.





5. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
800MG

tablet Discontinued ORAL N/A Jan 14, 2021
2.4GM/PACKET

for suspension Prescription ORAL AB Mar 2, 2023
800MG/PACKET

for suspension Prescription ORAL AB Mar 2, 2023





6. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 3 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
800MG

tablet Prescription ORAL AB Sep 29, 2017
800MG/PACKET

for suspension Prescription ORAL AB Oct 25, 2018
2.4GM/PACKET

for suspension Prescription ORAL AB Oct 25, 2018





7. IMPAX

Impax Laboratories Llc has filed for 2 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Impax.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.4GM/PACKET

for suspension Prescription ORAL AB Nov 20, 2020
800MG/PACKET

for suspension Prescription ORAL AB Nov 20, 2020


Manufacturing Plant Locations
New

Impax's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Impax as present at those locations.

Country City Firm Name
United States
Hayward Impax Laboratories, LLC.





8. IMPAX LABS INC

Impax Laboratories Inc has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
800MG

tablet Discontinued ORAL N/A Oct 23, 2017





9. INVAGEN PHARMS

Invagen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Invagen Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
800MG

tablet Prescription ORAL AB Oct 26, 2017
800MG/PACKET

for suspension Prescription ORAL AB Jul 12, 2024
2.4GM/PACKET

for suspension Prescription ORAL AB Jul 12, 2024





10. LUPIN LTD

Lupin Ltd has filed for 2 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
800MG/PACKET

for suspension Discontinued ORAL N/A Dec 23, 2021
2.4GM/PACKET

for suspension Discontinued ORAL N/A Dec 23, 2021


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





11. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
800MG

tablet Prescription ORAL AB Apr 19, 2023
800MG/PACKET

for suspension Prescription ORAL AB Apr 25, 2024
2.4GM/PACKET

for suspension Prescription ORAL AB Apr 25, 2024





12. MICRO LABS

Micro Labs Ltd has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Micro Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
800MG

tablet Prescription ORAL AB Feb 7, 2022


Manufacturing Plant Locations
New

Micro Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Micro Labs as present at those locations.

Country City Firm Name
India
Bangalore Micro Labs Limited
Verna Micro Labs Limited
Bengaluru Micro Labs Limited
Bengaluru Micro Labs Limited, Central Analytical Laboratory





13. RISING

Rising Pharma Holdings Inc has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
800MG

tablet Prescription ORAL AB Nov 29, 2018


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Rising Sun Rising Sun Veterinary Clinic
Fort Bragg Rising Tide Sea Vegetables
Mount Morris Rising Creek Bakery LLC
Decatur Rising Pharma Holdings, Inc
Saddle Brook Rising Pharmaceuticals, Inc.
East Brunswick Rising Pharma Holding, Inc.
Livingston Risingsun Iodine Products Corp.
Phoenix Rising Sun Farms Inc
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





14. SHANDONG XINHUA

Shandong Xinhua Pharmaceutical Co Ltd has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Shandong Xinhua.

Strength Dosage Form Availability Application Pathway TE code Launch Date
800MG

tablet Prescription ORAL AB Oct 24, 2024


Manufacturing Plant Locations
New

Shandong Xinhua's manufacturing plants are situated in 2 countries - China, United States. Given below are the details of these plant locations as well as the firm names of Shandong Xinhua as present at those locations.

Country City Firm Name
China
Zibo Shandong Xinhua Pharmaceutical Co., Ltd. First Plant
Zibo Shandong Xinhua Pharmaceutical Company Limited
Zibo Shandong Xinhua Pharmaceutical Co., Ltd. FDF Plant
United States
South El Monte Shandong Xinhua Pharmaceuticals (USA) Inc.





15. SINOTHERAPEUTICS INC

Sinotherapeutics Inc has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Sinotherapeutics Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
800MG

tablet Discontinued ORAL N/A Apr 9, 2020


Manufacturing Plant Locations
New

Sinotherapeutics Inc's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Sinotherapeutics Inc as present at those locations.

Country City Firm Name
China
Shanghai Sinotherapeutics Inc.





16. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
800MG

tablet Prescription ORAL AB May 9, 2024
2.4GM/PACKET

for suspension Prescription ORAL AB Sep 8, 2023
800MG/PACKET

for suspension Prescription ORAL AB Sep 8, 2023


Manufacturing Plant Locations
New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country City Firm Name
United States
East Brunswick Strides Pharma Inc.
Chestnut Ridge Strides Pharma, Inc.
India
Bangalore Strides Pharma Science Limited
Puducherry Strides Pharma Science Limited





17. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Sevelamer Carbonate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
800MG

tablet Prescription ORAL AB Aug 11, 2020